The CDC recommends eligible people 6 months and older receive an updated, bivalent Pfizer or Moderna vaccine that offers better protection against variants. Some people, like those who are immunocompromised or over 65, are eligible for a second bivalent dose.
CDC, FDA and other federal partners continue to monitor and evaluate the data, including whether additional booster doses may be needed for other populations in the future.
The CDC has guidance for everyone 6 months and older based on age and medical condition.